| 產(chǎn)品名稱 | MK 5108 - VX 689 |
| 產(chǎn)品貨號(hào) | Axon 1961 CAS [1010085-13-8] MF C22H21ClFN3O3SMW 461.94 Purity: 98% Optical purity: Optically pure Soluble in DMSO Description Highly potent and selective inhibitor of Aurora A kinase (AurA); MK5108 exhibits marked effects on the growth of tumor cells in vitro and in vivo; also enhances the antitumoractivity of Docetaxel without exacerbrating the toxicity in vivo References Certificates Categories Extra info T Shimomura et al. MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. Mol. Cancer Ther. 2010, 9(1), 157-166.? Certificate of Analysis Material Safety Data Sheet Cell Cycle Regulation Cell Signaling & Oncology Epigenetics EC 2.7.11.1 Aurora Inhibitor of Aurora A kinase Chemical name (1r,4r)-4-(3-chloro-2-fluorophenoxy)-1-((6-(thiazol-2-ylamino)pyridin-2-yl)methyl)cyclohexanecarboxylic acid Parent CAS No. [1010085-13-8] Order Size Unit Price Stock 5 mg €110.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
MK 5108 - VX 689Axon 1961 CAS [1010085-13-8] MF C22H21ClFN3O3S
Description
Highly potent and selective inhibitor of Aurora A kinase (AurA); MK5108 exhibits marked effects on the growth of tumor cells in vitro and in vivo; also enhances the antitumoractivity of Docetaxel without exacerbrating the toxicity in vivo
Inhibitor of Aurora A kinase
Chemical name(1r,4r)-4-(3-chloro-2-fluorophenoxy)-1-((6-(thiazol-2-ylamino)pyridin-2-yl)methyl)cyclohexanecarboxylic acid Parent CAS No.[1010085-13-8] |
| 產(chǎn)品資料 |
